pomalidomide
pomalidomide is listed in the FDA National Drug Code directory with 21 NDC codes, marketed under brand names including pomalidomide, Pomalidomide, Pomalyst. Available dosage forms: capsule, powder.
Drug details
- Generic Name
- pomalidomide
- Brand Names
- pomalidomide, Pomalidomide, Pomalyst
- Application Number
- ANDA210245
- Sponsor
- Novadoz Pharmaceuticals LLC
- NDC Codes
- 21
- Dosage Forms
- CAPSULE, POWDER
- Routes
- ORAL
- Active Ingredients
- POMALIDOMIDE, REGORAFENIB ANHYDROUS
Indications and Usage
1 INDICATIONS AND USAGE Pomalidomide capsules are a thalidomide analogue indicated for the treatment of adult patients: in combination with dexamethasone, for patients with multiple myeloma (MM) who have received at least two prior therapies including lenalidomide and a proteasome inhibitor and have demonstrated disease progression on or within 60 days of completion of the last therapy (1.1). 1.1 Multiple Myeloma Pomalidomide capsules, in combination with dexamethasone, is indicated for adult patients with multiple myeloma (MM) who have received at least two prior therapies including lenalidomide and a proteasome inhibitor and have demonstrated disease progression on or within 60 days of completion of the last therapy.